NLRP3 and obesity disorder: Furthermore, NLRP3 inflammsome could be activated by saturated fatty acid, ceramides, modified LDL, and hyperglycemia in obesity and type 2 diabetes (Wen et al., 2011; Jin and Flavell, 2013).